Men's preferences for prostate cancer screening: A discrete choice experiment

British Journal of Cancer

Volumn 108, Issue 3, 2013, Pages 533-541

  De Bekker Grob, E W ^a   Rose, J M ^b   Donkers, B ^c   Essink Bot, M L ^d   Bangma, C H ^a   Steyerberg, E W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CANCER THERAPY; DISCRETE CHOICE EXPERIMENT; EDUCATIONAL STATUS; EXPERIMENTAL TEST; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT PREFERENCE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK REDUCTION; TREATMENT OUTCOME; TUMOR BIOPSY;

AGED; CHOICE BEHAVIOR; EARLY DETECTION OF CANCER; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 84875220012     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.5     Document Type: Article

References (31)

1. Andriole GL, Crawford ED, Grubb 3rd RL, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360: 1310-1319.
2. Bech M, Kjaer T, Lauridsen J (2011) Does the number of choice sets matter Results from a web survey applying a discrete choice experiment. Health Econ 20: 273-286.
3. Bishop AJ, Marteau TM, Armstrong D, Chitty LS, Longworth L, Buxton MJ, Berlin C (2004) Women and health care professionals' preferences for Down's Syndrome screening tests: a conjoint analysis study. BJOG 111: 775-779.
4. Cantor SB, Volk RJ, Cass AR, Gilani J, Spann SJ (2002) Psychological benefits of prostate cancer screening: the role of reassurance. Health Expect 5: 104-113.
5. Daly A, Hess S, Train K (2012) Assuring finite moments for willingness to pay in random coefficient models. Transportation 39: 267-297.
6. de Bekker-Grob EW, Hofman R, Donkers B, van Ballegooijen M, Helmerhorst TJ, Raat H, Korfage IJ (2010a) Girls' preferences for HPV vaccination: a discrete choice experiment. Vaccine 28: 6692-6697.
7. de Bekker-Grob EW, Hol L, Donkers B, van Dam L, Habbema JD, van Leerdam ME, Kuipers EJ, Essink-Bot ML, Steyerberg EW (2010b) Labeled versus unlabeled discrete choice experiments in health economics: an application to colorectal cancer screening. Value Health 13: 315-323.
8. de Bekker-Grob EW, Ryan M, Gerard K (2012) Discrete choice experiments in health economics: a review of the literature. Health Econ 21: 145-172.
9. Draisma G, Boer R, Otto SJ, van der Cruijsen IW, Damhuis RA, Schroder FH, de Koning HJ (2003) Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 95: 868-878.
10. Hensher DA, Rose JM, Greene WH (2005) Applied Choice Analysis: A Primer. Cambridge University Press: Cambridge.
11. Herbild L, Bech M, Gyrd-Hansen D (2009) Estimating the Danish populations' preferences for pharmacogenetic testing using a discrete choice experiment. The case of treating depression. Value Health 12: 560-567.
12. Hol L, de Bekker-Grob EW, van Dam L, Donkers B, Kuipers EJ, Habbema JD, Steyerberg EW, van Leerdam ME, Essink-Bot ML (2010) Preferences for colorectal cancer screening strategies: a discrete choice experiment Br J Cancer 102: 972-980.
13. Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, Pihl CG, Stranne J, Holmberg E, Lilja H (2010) Mortality results from the Goteborg randomised population-based prostate-cancer screening trial. Lancet Oncol 11: 725-732.
14. Hundley V, Ryan M (2004) Are women's expectations and preferences for intrapartum care affected by the model of care on offer BJOG 111: 550-560.
15. Krinsky I, Robb AL (1986) On approximating the statistical properties of elasticities. Rev Econ Stat 68: 715-719.
16. Lancsar E, Louviere J (2008) Conducting discrete choice experiments to inform healthcare decision making: a user's guide. Pharmacoeconomics 26: 661-677.
17. Mangham LJ, Hanson K, McPake B (2009) How to do (or not to do). Designing a discrete choice experiment for application in a low-income country. Health Policy Plan 24: 151-158.
18. Pedersen LB, Gyrd-Hansen D, Kjaer T (2011) The influence of information and private versus public provision on preferences for screening for prostate cancer: a willingness-to-pay study. Health Policy 101: 277-289.
19. Phillips KA, Van Bebber S, Marshall D, Walsh J, Thabane L (2006) A review of studies examining stated preferences for cancer screening. Prev Chronic Dis 3: A75.
20. Ratcliffe J, Van Haselen R, Buxton M, Hardy K, Colehan J, Partridge M (2002) Assessing patients' preferences for characteristics associated with homeopathic and conventional treatment of asthma: a conjoint analysis study. Thorax 57: 503-508.
21. Roobol MJ, Kerkhof M, Schroder FH, Cuzick J, Sasieni P, Hakama M, Stenman UH, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis L, Recker F, Berenguer A, Ruutu M, Kujala P, Bangma CH, Aus G, Tammela TL, Villers A, Rebillard X, Moss SM, de Koning HJ, Hugosson J, Auvinen A (2009) Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC). Eur Urol 56: 584-591.
22. Ryan M (2004) Discrete choice experiments in health care. BMJ 328: 360-361.
23. Ryan M, Gerard K (2003) Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy 2: 55-64.
24. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Maattanen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360: 1320-1328.
25. Sculpher M, Bryan S, Fry P, de Winter P, Payne H, Emberton M (2004) Patients' preferences for the management of non-metastatic prostate cancer: discrete choice experiment. BMJ 328: 382.
26. Sennfalt K, Carlsson P, Varenhorst E (2006) Diffusion and economic consequences of health technologies in prostate cancer care in Sweden, 1991-2002. Eur Urol 49: 1028-1034.
27. Street DJ, Burgess L, Louviere JJ (2005) Constructing optimal and nearly optimal stated choice experiments. Intern J Res Marketing 22: 459-470.
28. Swait J (1994) A structural equation model of latent segmentation and product choice for cross sectional revealed preference choice data. J Retailing Consumer Serv 1: 77-89.
29. van Dam L, Hol L, de Bekker-Grob EW, Steyerberg EW, Kuipers EJ, Habbema JD, Essink-Bot ML, van Leerdam ME (2010) What determines individuals' preferences for colorectal cancer screening programmes? A discrete choice experiment. Eur J Cancer 46: 150-159.
30. Whynes DK, Philips Z, Avis M (2007) Why do women participate in the English cervical cancer screening programme? J Health Econ 26: 306-325.
31. Wordsworth S, Ryan M, Skatun D, Waugh N (2006) Women's preferences for cervical cancer screening: a study using a discrete choice experiment. Int J Technol Assess Health Care 22: 344-350.